Released on: March 21, 2008, 9:02 am

Press Release Author: GTCbio

Industry: Biotech

Press Release Summary: MONROVIA, CA - Dr. Berta Strulovici, Vice President of Basic
Research MRL, and Automated Biotechnology Head at Merck & Co. will give Keynote
Presentation at GTCbio's 4th Assay Development & Screening Technologies Conference,
June 5-6, 2008 in San Francisco, CA.



Press Release Body: Dr. Berta will present on the power of physiologically relevant
biological assays translating from early drug discovery to the clinic. Her talk will
show specific examples of the benefits of implementing complex, multiparametric
cellular assays on a large, industrial scale, along the drug discovery pipeline from
target ID to identifying potential responder populations. For target ID using RNAi
technology, multiparametric assays generate biological activity profiles that
provide valuable insight into complex disease models. Combined with miniaturization
technologies and sophisticated data analysis tools, Dr. Berta and her group have
identified novel targets for several therapeutic areas which are now either at
target validation stage or have progressed to lead ID.
Attendees will receive a review of the benefits of integrating complex assay
technologies from the early discovery phase to late in the pipeline and insight of
Merck's future strategy of profiling select compounds against disease-relevant
cellular assays to identify novel activities for existing compounds

GTCbio\'s 3rd Assay Development and Screening Technologies conference will provide
attendees with critical information to utilize in the discovery and development of
assays, while keeping them informed about the latest screening technologies for both
high-throughput screening and high-content screening. Topics being covered include
cell based assays, high throughput screening, high content screening, in vitro
assays and screening, novel assay and screening technologies, and target validation.
For more information visit www.gtcbio.com.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.


Web Site: http://www.gtcbio.com

Contact Details: Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax,
nina.tran@gtcbio.com